Pharma BD Deal Intelligence
Ranks computed across 828 graded deals (Critic + Outcome Score both present).
The Upjohn Co. and Swedish firm Pharmacia AB announced a $13 billion merger to form Pharmacia & Upjohn Inc., becoming the world ninth-largest pharmaceutical…
The $13 billion merger created a truly global enterprise with business activities across Europe, the US and Asia but required Fred Hassan turnaround to unlock…
Source summaries from our enrichment pipeline; follow links for originals.
All 6 sources with sentiment breakdown →
Pharmacia AB and The Upjohn Company merged in a $13 billion merger of equals to create Pharmacia & Upjohn, headquartered in London. The cross-border deal combined Pharmacia's European strength with Upjohn's US commercial presence.
| Deal | Year | Value | Outcome |
|---|---|---|---|
| Pharmacia Corporation / The Upjohn Company (this deal) | 1995 | $13.0B | 37 |
| Pharmacia Corporation / Sensus Drug Development Corporation | 2001 | $65M | 60 |
| Ciba-Geigy AG / Sandoz AG | 1996 | $36.3B | 98 |
| Sanofi SA / Regeneron Pharmaceuticals, Inc. | 2007 | $1.0B | 97 |
| AbbVie Inc. / Boehringer Ingelheim GmbH | 2016 | $2.2B | 95 |
| Amgen Inc. / Immunex Corporation | 2001 | $16.0B | 91 |
| Takeda Pharmaceutical Company Ltd. / Nimbus Lakshmi | 2022 | $6.0B | 82 |
← Browse all deals · How we score deals
More: 1995 deals · Dermatology deals